Arrowhead Pharmaceuticals, Inc. (ARWR)
86.74
-0.37
(-0.42%)
USD |
NASDAQ |
Aug 24, 16:00
86.74
0.00 (0.00%)
After-Hours: 19:19
Arrowhead Pharmaceuticals 1 Year Total Returns (Daily) : 319.8% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 319.8% |
| August 20, 2026 | 333.0% |
| August 19, 2026 | 350.2% |
| August 18, 2026 | 341.5% |
| August 17, 2026 | 332.5% |
| August 14, 2026 | 361.3% |
| August 13, 2026 | 328.2% |
| August 12, 2026 | 390.2% |
| August 11, 2026 | 418.5% |
| August 10, 2026 | 437.9% |
| August 07, 2026 | 445.8% |
| August 06, 2026 | 426.2% |
| August 05, 2026 | 427.7% |
| August 04, 2026 | 444.1% |
| August 03, 2026 | 439.9% |
| July 31, 2026 | 435.8% |
| July 30, 2026 | 456.0% |
| July 29, 2026 | 441.6% |
| July 28, 2026 | 429.5% |
| July 27, 2026 | 443.4% |
| July 24, 2026 | 426.4% |
| July 23, 2026 | 445.1% |
| July 22, 2026 | 492.9% |
| July 21, 2026 | 406.6% |
| July 20, 2026 | 327.5% |
| Date | Value |
|---|---|
| July 17, 2026 | 294.2% |
| July 16, 2026 | 290.0% |
| July 15, 2026 | 307.4% |
| July 14, 2026 | 286.4% |
| July 13, 2026 | 304.8% |
| July 10, 2026 | 305.1% |
| July 09, 2026 | 344.9% |
| July 08, 2026 | 388.8% |
| July 07, 2026 | 416.4% |
| July 06, 2026 | 415.5% |
| July 02, 2026 | 397.0% |
| July 01, 2026 | 399.9% |
| June 30, 2026 | 415.9% |
| June 29, 2026 | 400.6% |
| June 26, 2026 | 390.9% |
| June 25, 2026 | 406.2% |
| June 24, 2026 | 400.1% |
| June 23, 2026 | 415.2% |
| June 22, 2026 | 435.2% |
| June 18, 2026 | 423.8% |
| June 17, 2026 | 422.8% |
| June 16, 2026 | 387.6% |
| June 15, 2026 | 390.2% |
| June 12, 2026 | 359.4% |
| June 11, 2026 | 344.5% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Sarepta Therapeutics, Inc. | -6.33% |
| Intellia Therapeutics, Inc. | 26.81% |
| Denali Therapeutics, Inc. | 63.62% |
| Twist Bioscience Corp. | 450.0% |
| Revolution Medicines, Inc. | 474.2% |